Correlation Between GlaxoSmithKline PLC and Perrigo Company
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Perrigo Company at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Perrigo Company into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Perrigo Company PLC, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Perrigo Company and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Perrigo Company. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Perrigo Company.
Diversification Opportunities for GlaxoSmithKline PLC and Perrigo Company
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and Perrigo is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Perrigo Company PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Perrigo Company and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Perrigo Company. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Perrigo Company has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Perrigo Company go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Perrigo Company
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Perrigo Company. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.7 times less risky than Perrigo Company. The stock trades about -0.3 of its potential returns per unit of risk. The Perrigo Company PLC is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 2,577 in Perrigo Company PLC on August 28, 2024 and sell it today you would earn a total of 263.00 from holding Perrigo Company PLC or generate 10.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Perrigo Company PLC
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Perrigo Company |
GlaxoSmithKline PLC and Perrigo Company Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Perrigo Company
The main advantage of trading using opposite GlaxoSmithKline PLC and Perrigo Company positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Perrigo Company can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Perrigo Company will offset losses from the drop in Perrigo Company's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Perrigo Company vs. Prestige Brand Holdings | Perrigo Company vs. Amphastar P | Perrigo Company vs. Pacira BioSciences, | Perrigo Company vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |